Merck v. Integra

CHAL 37

Karen I Boyd, boyd@fr.com, Fish and Richardson, PC, 500 Arguello Street, Suite 500, Redwood City, CA 94063
Last year's decision in Merck v. Integra affirmed a broad exemption from patent infringement for research activities related to seeking regulatory approval. I will discuss the Supreme Court's decision and its impact on both patentees and those engaging in development of pre-clinical candidates.